Skip to content
PoliticalRepoPoliticalRepo

European Union · Record · CJ

CELEX 62011CJ0130

Judgment of the Court (Fourth Chamber), 19 July 2012.#Neurim Pharmaceuticals (1991) Ltd v Comptroller-General of Patents.#Reference for a preliminary ruling from the Court of Appeal (England and Wales) (Civil Division).#Medicinal products for human use — Supplementary protection certificate — Regulation (EC) No 469/2009 — Article 3 — Conditions for obtaining a supplementary protection certificate — Medicinal product having obtained a valid marketing authorisation — First authorisation — Product successively authorised as a veterinary medicinal product and a human medicinal product.#Case C‑130/11.

decidedEuropean Union· Court of Justice of the European Union· EN

Introduced

19 July 2012

Last action

19 July 2012 · Decided

Status

decided

Sponsors

—

Subjects

Discovery layer

Source updated

19 July 2012

Official sourceDownload fileView documentsShare

Records

Official record CELEX 62011CJ0130 from European Union at Court of Justice of the European Union. Dated 19 July 2012. Status: decided.

Timeline

  1. 19 July 2012

    Decided

    Source: work_date_document

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

23 official files

Domstolens dom (fjärde avdelningen) av den 19 juli 2012.#Neurim Pharmaceuticals (1991) Ltd mot Comptroller-General of Patents.#Begäran om förhandsavgörande från Court of Appeal (England & Wales) (Civil Division).#Humanläkemedel – Tilläggsskydd – Förordning (EG) nr 469/2009 – Artikel 3 – Villkor för erhållande – Läkemedel som erhållit ett giltigt godkännande för försäljning – Första godkännande – Produkt som först godkänts som veterinärläkemedel och därefter som humanläkemedel.#Mål C-130/11.

View fileDownload file

Reading translation

Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

  • Domstolens dom (fjärde avdelningen) av den 19 juli 2012.#Neurim Pharmaceuticals (1991) Ltd mot Comptroller-General of Patents.#Begäran om förhandsavgörande från Court of Appeal (England & Wales) (Civil Division).#Humanläkemedel – Tilläggsskydd – Förordning (EG) nr 469/2009 – Artikel 3 – Villkor för erhållande – Läkemedel som erhållit ett giltigt godkännande för försäljning – Första godkännande – Produkt som först godkänts som veterinärläkemedel och därefter som humanläkemedel.#Mål C-130/11.

    judgment · SV · 19 July 2012

    ViewDownloadOpen at official source

  • Presuda Suda (četvrto vijeće) od 2012. srpanj 19.#Neurim Pharmaceuticals (1991) Ltd protiv Comptroller General of Patents.#Zahtjev za prethodnu odluku podnesena po Court of Appeal (England & Wales) (Civil Division).#Predmet C-130/11.

    judgment · HR · 19 July 2012

    ViewDownloadOpen at official source

    Reading translation

    Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

    On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

  • Rozsudok Súdneho dvora (štvrtá komora) z 19. júla 2012.#Neurim Pharmaceuticals (1991) Ltd proti Comptroller-General of Patents.#Návrh na začatie prejudiciálneho konania podaný Court of Appeal (England & Wales) (Civil Division).#Humánne lieky – Dodatkové ochranné osvedčenie – Nariadenie (ES) č. 469/2009 – Článok 3 – Podmienky na získanie – Liek, ktorý získal platné oprávnenie na uvedenie na trh – Prvé oprávnenie – Výrobok, ktorý získal oprávnenie postupne ako veterinárne liečivo a humánny liek.#Vec C-130/11.

    judgment · SK · 19 July 2012

    ViewDownloadOpen at official source

    Reading translation

    Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

    On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

  • Euroopa Kohtu otsus (neljas koda), 19.7.2012.#Neurim Pharmaceuticals (1991) Ltd versus Comptroller-General of Patents.#Eelotsusetaotlus, mille on esitanud Court of Appeal (England & Wales) (Civil Division).#Inimtervishoius kasutatavad ravimid – Täiendava kaitse tunnistus – Määrus (EÜ) nr 469/2009 – Artikkel 3 – Saamise tingimused – Ravim, millele on antud kehtiv müügiluba – Esmane müügiluba – Toode, millele on kõigepealt antud veterinaarravimi ja seejärel inimtervishoius kasutatava ravimi müügiluba.#Kohtuasi C‑130/11.

    judgment · ET · 19 July 2012

    ViewDownloadOpen at official source

    Reading translation

    Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

    On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

  • Arrêt de la Cour (quatrième chambre) du 19 juillet 2012.#Neurim Pharmaceuticals (1991) Ltd contre Comptroller-General of Patents.#demande de décision préjudicielle, introduite par la Court of Appeal (England & Wales) (Civil Division).#Médicaments à usage humain — Certificat complémentaire de protection — Règlement (CE) no 469/2009 — Article 3 — Conditions d’obtention — Médicament ayant obtenu une autorisation de mise sur le marché en cours de validité — Première autorisation — Produit autorisé successivement comme médicament vétérinaire et médicament humain.#Affaire C-130/11.

    judgment · FR · 19 July 2012

    ViewDownloadOpen at official source

    Reading translation

    Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

    On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

  • Hotărârea Curții (Camera a patra) din 19 iulie 2012.#Neurim Pharmaceuticals (1991) Ltd împotriva Comptroller‑General of Patents.#Cerere de pronunțare a unei hotărâri preliminare formulată de Court of Appeal (England & Wales) (Civil Division).#Medicamente de uz uman — Certificat suplimentar de protecție — Regulamentul (CE) nr. 469/2009 — Articolul 3 — Condiții de obținere — Medicament care a obținut o autorizație validă de introducere pe piață — Prima autorizație — Produs autorizat succesiv ca produs medicamentos veterinar și ca produs medicamentos de uz uman.#Cauza C-130/11.

    judgment · RO · 19 July 2012

    ViewDownloadOpen at official source

    Reading translation

    Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

    On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

  • Acórdão do Tribunal de Justiça (Quarta Secção) de 19 de julho de 2012.#Neurim Pharmaceuticals (1991) Ltd contra Comptroller‑General of Patents.#Pedido de decisão prejudicial apresentado pela Court of Appeal (England & Wales) (Civil Division).#Medicamentos para uso humano — Certificado complementar de proteção — Regulamento (CE) n.° 469/2009 — Artigo 3.° — Requisitos de obtenção — Medicamento que obteve uma autorização de colocação no mercado ainda válida — Primeira autorização — Produto autorizado sucessivamente como medicamento veterinário e como medicamento para uso humano.#Processo C‑130/11.

    judgment · PT · 19 July 2012

    ViewDownloadOpen at official source

    Reading translation

    Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

    On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

  • Domstolens dom (Fjerde Afdeling) af 19. juli 2012.#Neurim Pharmaceuticals (1991) Ltd mod Comptroller-General of Patents.#Anmodning om præjudiciel afgørelse indgivet af Court of Appeal (England & Wales) (Civil Division).#Humanmedicinske lægemidler – supplerende beskyttelsescertifikat – forordning (EF) nr. 469/2009 – artikel 3 – betingelser for opnåelse – lægemiddel, der har opnået en gyldig markedsføringstilladelse – første tilladelse – produkt successivt godkendt som veterinærmedicinsk og humanmedicinsk lægemiddel.#Sag C-130/11.

    judgment · DA · 19 July 2012

    ViewDownloadOpen at official source

    Reading translation

    Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

    On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

  • A Bíróság ítélete (negyedik tanács), 2012. július 19.#Neurim Pharmaceuticals (1991) Ltd kontra Comptroller‑General of Patents.#A Court of Appeal (England & Wales) (Civil Division) (Egyesült Királyság) által benyújtott előzetes döntéshozatal iránti kérelem.#Emberi felhasználásra szánt gyógyszerek – Kiegészítő oltalmi tanúsítvány – 469/2009/EK rendelet – 3. cikk – Megszerzési feltételek – Gyógyszer, amelyre érvényes forgalombahozatali engedélyt adtak – Első engedély – Egymást követően állatgyógyászati készítményként és emberi felhasználásra szánt gyógyszerként engedélyezett termék.#C‑130/11. sz. ügy.

    judgment · HU · 19 July 2012

    ViewDownloadOpen at official source

    Reading translation

    Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

    On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

  • Tiesas (ceturtā palāta) 2012. gada 19. jūlija spriedums.#Neurim Pharmaceuticals (1991) Ltd pret Comptroller‑General of Patents.#Court of Appeal (England & Wales) (Civil Division) lūgums sniegt prejudiciālu nolēmumu.#Cilvēkiem paredzētas zāles – Papildu aizsardzības sertifikāts – Regula (EK) Nr. 469/2009 – 3. pants – Saņemšanas nosacījumi – Zāles, par kurām ir saņemta tirdzniecības atļauja, kura ir spēkā – Pirmā atļauja – Produkts, kuram secīgi piešķirta atļauja kā dzīvniekiem paredzētām zālēm un kā cilvēkiem paredzētām zālēm.#Lieta C‑130/11.

    judgment · LV · 19 July 2012

    ViewDownloadOpen at official source

    Reading translation

    Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

    On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

  • 2012 m. liepos 19 d. Teisingumo Teismo (ketvirtoji kolegija) sprendimas.#Neurim Pharmaceuticals (1991) Ltd prieš Comptroller-General of Patents.#Court of Appeal (England & Wales) (Civil Division) prašymas priimti prejudicinį sprendimą.#Žmonėms skirti vaistai – Papildomas apsaugos liudijimas – Reglamentas (EB) Nr. 469/2009 – 3 straipsnis – Išdavimo sąlygos – Vaistas, kurį pateikti rinkai buvo išduotas galiojantis leidimas – Pirmasis leidimas – Produktas, dėl kurio paeiliui išduoti leidimai pateikti rinkai kaip veterinarinį vaistą ir kaip žmonėms skirtą vaistą.#Byla C‑130/11.

    judgment · LT · 19 July 2012

    ViewDownloadOpen at official source

    Reading translation

    Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

    On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

  • Απόφαση του Δικαστηρίου (τέταρτο τμήμα) της 19ης Ιουλίου 2012.#Neurim Pharmaceuticals (1991) Ltd κατά Comptroller-General of Patents.#Αίτηση του Court of Appeal (England & Wales) (Civil Division) για την έκδοση προδικαστικής αποφάσεως.#Φάρμακα που προορίζονται για ανθρώπινη χρήση — Συμπληρωματικό πιστοποιητικό προστασίας — Κανονισμός (ΕΚ) 469/2009 — Άρθρο 3 — Προϋποθέσεις χορηγήσεως — Φάρμακο για το οποίο έχει χορηγηθεί ισχύουσα άδεια κυκλοφορίας στην αγορά — Πρώτη άδεια κυκλοφορίας — Προϊόν για το οποίο χορηγήθηκαν διαδοχικές άδειες ως φάρμακο για κτηνιατρική και για ανθρώπινη χρήση.#Υπόθεση C‑130/11.

    judgment · EL · 19 July 2012

    ViewDownloadOpen at official source

    Reading translation

    Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

    On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

  • Sentencia del Tribunal de Justicia (Sala Cuarta) de 19 de julio de 2012.#Neurim Pharmaceuticals (1991) Ltd contra Comptroller-General of Patents.#Petición de decisión prejudicial planteada por la Court of Appeal England & Wales (Civil Division).#Medicamentos para uso humano — Certificado complementario de protección — Reglamento (CE) nº 469/2009 — Artículo 3 — Requisitos para su obtención — Medicamento que haya obtenido una autorización de comercialización vigente — Primera autorización — Producto autorizado sucesivamente como medicamento veterinario y medicamento para uso humano.#Asunto C‑130/11.

    judgment · ES · 19 July 2012

    ViewDownloadOpen at official source

    Reading translation

    Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

    On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

  • Sentenza della Corte (Quarta Sezione) del 19 luglio 2012.#Neurim Pharmaceuticals (1991) Ltd contro Comptroller-General of Patents.#[domanda di pronuncia pregiudiziale proposta dalla Court of Appeal England & Wales) (Civil Division].#Medicinali per uso umano — Certificato protettivo complementare — Regolamento (CE) n. 469/2009 — Articolo 3 — Condizioni di rilascio — Medicinale per cui sia stata concessa un’autorizzazione di immissione in commercio in corso di validità — Prima autorizzazione — Prodotto autorizzato dapprima come medicinale per uso veterinario e poi come medicinale per uso umano.#Causa C‑130/11.

    judgment · IT · 19 July 2012

    ViewDownloadOpen at official source

    Reading translation

    Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

    On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

  • Sodba Sodišča (četrti senat) z dne 19. julija 2012.#Neurim Pharmaceuticals (1991) Ltd proti Comptroller‑General of Patents.#Predlog za sprejetje predhodne odločbe, ki ga je vložilo Court of Appeal (England & Wales) (Civil Division).#Zdravila za uporabo v humani medicini – Dodatni varstveni certifikat – Uredba (ES) št. 469/2009 – Člen 3 – Pogoji za pridobitev – Zdravilo, za katero je bilo pridobljeno veljavno dovoljenje za promet – Prvo dovoljenje – Izdelek, ki je bil najprej dovoljen kot zdravilo za uporabo v veterinarski medicini, nato pa kot zdravilo za uporabo v humani medicini.#Zadeva C‑130/11.

    judgment · SL · 19 July 2012

    ViewDownloadOpen at official source

    Reading translation

    Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

    On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

  • Решение на Съда (четвърти състав) от 19 юли 2012 г.#Neurim Pharmaceuticals (1991) Ltd срещу Comptroller-General of Patents.#Преюдициално запитване, отправено от Court of Appeal (England & Wales) (Civil Division.#Лекарствени продукти за хуманна употреба — Сертификат за допълнителна закрила — Регламент (ЕО) № 469/2009 — Член 3 — Условия за придобиване — Лекарствен продукт, за който е получено валидно към момента разрешение за пускане на пазара — Първо разрешение — Продукт, разрешен последователно като ветеринарен лекарствен продукт и като лекарствен продукт за хуманна употреба.#Дело C‑130/11.

    judgment · BG · 19 July 2012

    ViewDownloadOpen at official source

    Reading translation

    Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

    On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

  • Sentenza tal-Qorti tal-Ġustizzja (Ir-Raba’ Awla) tad-19 ta’ Lulju 2012.#Neurim Pharmaceuticals (1991) Ltd vs Comptroller-General of Patents.#Talba għal deċiżjoni preliminari mressqa mill-Court of Appeal (England & Wales) (Civil Division).#Prodotti mediċinali għall-użu mill-bniedem — Ċertifikat ta’ protezzjoni supplimentari — Regolament (KE) Nru 469/2009 — Artikolu 3 — Kundizzjonijiet għal kisba — Prodott mediċinali li jkun kiseb awtorizzazzjoni ta’ tqegħid fis-suq valida — L-ewwel awtorizzazzjoni — Prodott awtorizzat suċċessivament bħala prodott mediċinali għall-użu veterinarju u prodott mediċinali għall-użu mill-bniedem.#Kawża C-130/11.

    judgment · MT · 19 July 2012

    ViewDownloadOpen at official source

    Reading translation

    Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

    On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

  • Arrest van het Hof (Vierde kamer) van 19 juli 2012.#Neurim Pharmaceuticals (1991) Ltd tegen Comptroller-General of Patents.#Verzoek van de Court of Appeal (England and Wales) (Civil Division) om een prejudiciële beslissing.#Geneesmiddelen voor menselijk gebruik – Aanvullend beschermingscertificaat – Verordening (EG) nr. 469/2009 – Artikel 3 – Voorwaarden voor verkrijging – Geneesmiddel waarvoor van kracht zijnde vergunning voor in handel brengen is afgegeven – Eerste vergunning – Opeenvolgende vergunningen voor in handel brengen van product als geneesmiddel voor diergeneeskundig gebruik en als geneesmiddel voor menselijk gebruik.#Zaak C‑130/11.

    judgment · NL · 19 July 2012

    ViewDownloadOpen at official source

    Reading translation

    Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

    On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

  • Urteil des Gerichtshofs (Vierte Kammer) vom 19. Juli 2012.#Neurim Pharmaceuticals (1991) Ltd gegen Comptroller-General of Patents.#Vorabentscheidungsersuchen des Court of Appeal [England & Wales], Civil Division.#Humanarzneimittel – Ergänzendes Schutzzertifikat – Verordnung (EG) Nr. 469/2009 – Art. 3 – Bedingungen für die Erteilung – Arzneimittel, für das eine gültige Genehmigung für das Inverkehrbringen erteilt wurde – Erste Genehmigung – Zunächst als Tier-, dann als Humanarzneimittel zugelassenes Erzeugnis.#Rechtssache C-130/11.

    judgment · DE · 19 July 2012

    ViewDownloadOpen at official source

    Reading translation

    Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

    On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

  • Unionin tuomioistuimen tuomio (neljäs jaosto) 19.7.2012.#Neurim Pharmaceuticals (1991) Ltd vastaan Comptroller-General of Patents.#Court of Appealin (England & Wales) (Civil Division) esittämä ennakkoratkaisupyyntö.#Ihmisille tarkoitetut lääkkeet – Lisäsuojatodistus – Asetus (EY) N:o 469/2009 – 3 artikla – Edellytykset saamiselle – Lääke, jolle on annettu voimassa oleva markkinoille saattamista koskeva lupa – Ensimmäinen lupa – Tuote, jolle on ensin annettu lupa eläimille tarkoitettuna lääkkeenä ja sittemmin ihmisille tarkoitettuna lääkkeenä.#Asia C-130/11.

    judgment · FI · 19 July 2012

    ViewDownloadOpen at official source

    Reading translation

    Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

    On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

  • Wyrok Trybunału (czwarta izba) z dnia 19 lipca 2012 r.#Neurim Pharmaceuticals (1991) Ltd przeciwko Comptroller-General of Patents.#Wniosek o wydanie orzeczenia w trybie prejudycjalnym złożony przez Court of Appeal (England & Wales), Civil Division.#Produkty lecznicze stosowane u ludzi – Dodatkowe świadectwo ochronne – Rozporządzenie (WE) nr 469/2009 – Artykuł 3 – Warunki uzyskania – Produkt leczniczy, dla którego wydano ważne zezwolenie na obrót – Pierwsze zezwolenie – Produkt dopuszczony kolejno jako weterynaryjny produkt leczniczy i jako produkt leczniczy stosowany u ludzi.#Sprawa C‑130/11.

    judgment · PL · 19 July 2012

    ViewDownloadOpen at official source

    Reading translation

    Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

    On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

  • Rozsudek Soudního dvora (čtvrtého senátu) ze dne 19. července 2012.#Neurim Pharmaceuticals (1991) Ltd v. Comptroller-General of Patents.#Žádost o rozhodnutí o předběžné otázce podaná Court of Appeal England & Wales) (Civil Division).#Humánní léčivé přípravky – Dodatkové ochranné osvědčení – Nařízení (ES) č. 469/2009 – Článek 3 – Podmínky získání – Platně registrovaný léčivý přípravek – První registrace – Výrobek postupně registrovaný jako veterinární léčivý přípravek a jako humánní léčivý přípravek.#Věc C‑130/11.

    judgment · CS · 19 July 2012

    ViewDownloadOpen at official source

    Reading translation

    Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

    On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

  • Judgment of the Court (Fourth Chamber), 19 July 2012.#Neurim Pharmaceuticals (1991) Ltd v Comptroller-General of Patents.#Reference for a preliminary ruling from the Court of Appeal (England and Wales) (Civil Division).#Medicinal products for human use — Supplementary protection certificate — Regulation (EC) No 469/2009 — Article 3 — Conditions for obtaining a supplementary protection certificate — Medicinal product having obtained a valid marketing authorisation — First authorisation — Product successively authorised as a veterinary medicinal product and a human medicinal product.#Case C‑130/11.

    judgment · EN · 19 July 2012

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.